CIK 0001771910 · Non-accelerated filer<br>Smaller reporting company
ADC Therapeutics SA
Sign in to watch- Ticker
- ADCT
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- Phone
- 41 21 653 02 00
- Business address
- BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, Switzerland, 1066
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Other acquisition 10% owner acquired 9,788,944 shares (other)
- 4 Other disposition See Explanations disposed of 451,856 shares (other)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Executive Officer gave up 26,758 shares (to pay taxes)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- DEFA14A Proxy Proxy Materials
- PRE 14A Proxy Proxy Statement (Preliminary)
- ARS Other Annual Report to Security Holders
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award Chief Legal Officer acquired 220,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 230,000 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 41,900 shares (grant or award)
Page 6 of 23 · 441 filings